Rheumatology Research Foundation
Analysis
Rheumatology Research Foundation is a registered charity in United States, based in Atlanta, GA. It received its IRS tax-exemption ruling in July 1988, 38 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending June 2023, Rheumatology Research Foundation reported income of $13.0m and spending of $17.4m, spending 133% of what it took in. Across the 5 years on record, from June 2019 to June 2023, income fell from $13.5m to $13.0m (-3.6%), an average of -0.9% a year. The sharpest change came in the year to June 2021, when income rose by 130%. Over the whole period it spent 111% of the income it received.
Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Rheumatology Research Foundation sits at the 86th percentile: it is larger than about 86% of them. Against every charity in United States with reported income it ranks in the 96th percentile, and in the 97th percentile within GA. Charities of a similar size with the same main cause include Duffy Health Center Inc ($13.0m), Transitions of Western Illinois Inc ($13.0m) and Stop Soldier Suicide ($13.0m).
On its Form 990 for the period ending June 2023, revenue came from contributions and grants 97% of the total. Compensation of current officers, directors and key employees was $47k (0.3% of expenses). At year end it held assets of $70.5m against liabilities of $502k, net assets of $70.0m.
Income and spending
Where the income comes from
- Contributions & grants 97%
- Other 3.4%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Duffy Health Center Inc | Hyannis | $13.0m |
| Transitions of Western Illinois Inc | Quincy | $13.0m |
| Stop Soldier Suicide | Durham | $13.0m |
| Union for International Cancer Control | Switzerland | $13.0m |